SALT OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUND OR CRYSTAL THEREOF, PHARMACEUTICAL COMPOSITION, AND FLT3 INHIBITOR
    4.
    发明申请
    SALT OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUND OR CRYSTAL THEREOF, PHARMACEUTICAL COMPOSITION, AND FLT3 INHIBITOR 有权
    含氮杂环化合物或其结晶的盐,药物组合物和FLT3抑制剂

    公开(公告)号:US20160229812A1

    公开(公告)日:2016-08-11

    申请号:US15130168

    申请日:2016-04-15

    Abstract: An object of the present invention is to provide a compound and pharmaceutical composition showing superior stability and/or solubility, etc. and having superior FLT3 inhibitory activity. The present invention provides a salt of (S,E)-N-(1-((5-(2-((4-cyanophenyl)amino)-4-(propylamino)pyrimidin-5-yl)pent-4-yn-1-yl)amino)-1-oxopropan-2-yl)-4-(dimethylamino)-N-methylbut-2-enamide, or a crystal thereof. Since the salt or a crystal thereof has superior FLT3 inhibitory activity and shows superior physicochemical properties as drugs, such as storage stability, solubility, and so forth, it is useful for treatments of diseases or conditions relating to FLT3. The present invention also provides a pharmaceutical composition and FLT3 inhibitor containing the salt or a crystal thereof.

    Abstract translation: 本发明的目的是提供显示出优异的稳定性和/或溶解性等并且具有优异的FLT3抑制活性的化合物和药物组合物。 本发明提供了(S,E)-N-(1 - ((5-(2 - ((4-氰基苯基)氨基)-4-(丙基氨基)嘧啶-5-基)戊-4-炔 -1-基)氨基)-1-氧代丙-2-基)-4-(二甲基氨基)-N-甲基丁-2-烯酰胺或其结晶。 由于盐或其结晶具有优异的FLT3抑制活性,并且作为药物,例如储存稳定性,溶解度等,具有优异的物理化学性质,因此可用于治疗与FLT3有关的疾病或病症。 本发明还提供含有盐或其结晶的药物组合物和FLT3抑制剂。

Patent Agency Ranking